首页 | 官方网站   微博 | 高级检索  
     

驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识(2019年版)
引用本文:梁晓华,黄若凡,詹 琼. 驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识(2019年版)[J]. 中国癌症杂志, 2019, 29(1): 71-80. DOI: 10.19401/j.cnki.1007-3639.2019.01.011
作者姓名:梁晓华  黄若凡  詹 琼
作者单位:复旦大学附属华山医院肿瘤科,上海 200040
基金项目:上海市卫生计生委协同创新集群项目(2019CXJQ03)。
摘    要:驱动基因阳性非小细胞肺癌(non-small cell lung cancer,NSCLC)脑转移是临床关注的热点,综合治疗是原则,不同治疗手段的合理组合和顺序安排,对延长患者生存期和提高生活质量有着重要意义。上海市抗癌协会脑转移瘤专业委员会组织专家制订了本共识,以规范驱动基因阳性NSCLC脑转移的诊治。

关 键 词:非小细胞肺癌  驱动基因突变  靶向治疗  放射治疗  

Shanghai expert consensus on the management of brain metastasis of non-small cell lung cancer with driver gene mutations
LIANG Xiaohua,HUANG Ruofan,ZHAN Qiong. Shanghai expert consensus on the management of brain metastasis of non-small cell lung cancer with driver gene mutations[J]. China Oncology, 2019, 29(1): 71-80. DOI: 10.19401/j.cnki.1007-3639.2019.01.011
Authors:LIANG Xiaohua  HUANG Ruofan  ZHAN Qiong
Affiliation:Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China
Abstract:Brain metastasis of non-small cell lung cancer (NSCLC) with driver gene mutation is becoming a clinical highlight. Rational combination and sequencing of different treatment methods are of great significance for prolonging the survival time and improving the quality of life of patients. Experts from the Committee of Brain Metastases, Shanghai Anti-Cancer Association have formulated this consensus to standardize the diagnosis and treatment of brain metastasis from NSCLC with driver gene mutation.
Keywords:Non-small cell lung cancer  Driver gene mutation   Targeted therapy  Radiotherapy  
点击此处可从《中国癌症杂志》浏览原始摘要信息
点击此处可从《中国癌症杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号